Drugs that target insulin pathways to slow or stop the growth of brain tumors are going in the right direction but appear to be on the wrong track, according to new research at Rice University. - See more at: news.rice.edu/2015/04/20/new-tactic-targets-brain-tumors-2/
- New tactic targets brain tumors ( Download)
- Targeting TREM-1 in solid tumors ( Download)
- Targeting Tumors With Electricity ( Download)
- Current challenges in targeting solid tumors with CAR T-cells ( Download)
- BI 907828: targeting MDM2 in solid tumors ( Download)
- Updates in targeting mesothelin-expressing solid tumors ( Download)
- Live Session 3: Primary Bone Tumors ( Download)
- P329G-targeting CAR-T cells designed to target solid tumors ( Download)
- Self-assembled Polymeric Nanoparticles for Drug Targeting to Tumors ( Download)
- Customized vaccines targeting individual tumors ( Download)
- REFLEXION: TARGETING TUMORS FROM THE INSIDE OUT ( Download)
- Targeting hypoxia in tumors with combination therapy ( Download)
- Targeted Delivery of Drugs to Brain Tumors ( Download)
- How CyberKnife M6 Targets Tumors ( Download)
- STEAP1 targeting CAR-T therapy for solid tumors ( Download)